Order Processing Updates:
The Vaccines for Children (VFC) Program is currently not experiencing any delays in order review. Please note if you have an order in “Corrections Needed” status, review your order as soon as you have a chance and re-submit with corrections to prevent additional delays in fulfillment of your order. Providers can expect to receive their vaccines within 14 days after receiving the order processed notification. Please contact us at the VFC Customer Service Center if vaccines have not arrived within two weeks of your order processed confirmation.
Regular Vaccine Supply Information:
Td Vaccine:
Please remember to order and administer Tdap instead of Td whenever possible.
| BRAND |
NDC |
NDC Description |
Currently Available? |
| TENIVAC |
49281-0215-15 |
TD; 10-pack of syringes |
Yes |
| TENIVAC |
49281-0215-10 |
TD; 10-pack of single dose vials |
Yes |
| TDVAX |
13533-0131-01
|
TD; 10-pack of single dose vials |
No longer available (as of 1/10/2025) |
Hib Vaccine
As of February 20, 2024, Hiberix (NDC 58160-0818-11) is no longer available. The new presentation of Hiberix (NDC 58160-0726-15) will be available to order starting March 1, 2024. Alternate brands of Hib are still available to order (ActHIB and PedvaxHib).
RSV
Nirsevimab/Beyfortus™: Both 50 and 100mg presentations have begun to ship for providers that submitted their pre-book requests. For providers that did not submit a pre-book request, doses will be allocated to your location based on available supply.
Clesrovimab/Enflonsia™: Currently unavailable, but anticipated to be available later this season. We will keep you updated as we hear more information from CDC when this will be available for shipping.
COVID-19 Vaccine:
| Product |
Age Group |
Currently Available? |
| Pfizer (6m-4y) |
6 months – 4 years |
No |
| Moderna (6m-11y) |
6 months – 11 years |
No |
| Pfizer (5-11y) |
5 years – 11 years |
No |
| Spikevax (Moderna) (12y+) |
12 years+ |
No |
| Comirnaty (Pfizer) (12y+) |
12 years+ |
No |
| Novavax |
12 years+ |
No |
2024-2025 COVID-19 Vaccine: Due to current vaccine shelf life and availability, COVID-19 vaccine orders for the 2024-2025 formulations have now closed. Pfizer COVID-19 vaccine ordering closed on August 6, 2025, and Moderna COVID-19 vaccine ordering ended on August 20, 2025.
In the meantime, providers may continue to administer the 2024–2025 formulations of COVID-19 vaccine products until on-hand inventory has depleted, or until vaccine reaches expiration or deauthorization. Once expired, providers must remove the product from the vaccine storage unit, report expired doses in myCAvax and return expired doses to McKesson.
For more information about COVID-19 vaccine interchangeability, refer to CDC’s COVID-19 Implementation guidance.
2025-2026 COVID-19 Vaccine: More information will be shared about updated COVID-19 formulations for 2025–2026 when we have more details. It is currently not known when supplies of 2025–2026 vaccines will become available.
Pneumococcal Conjugate Vaccine
As of September 1, 2023, Prevnar 13 is no longer available. However, Prevnar 20 (NDC: 00005-2000-10) and Vaxneuvance (NDC: 00006-4329-03) are still available for ordering.
Meningococcal Vaccine:
As of August 9, 2024, MenQuadfi Single Dose Vials – 5 per box (NDC 49281-0590-05) presentation has been discontinued and is no longer available. An alternate presentation of MenQuadfi Single Dose Vials – 10 per box (NDC 49281-0590-10) is available.
As of September 1, 2023, the new Menveo one-vial is available for ordering through the VFC Program. However, the existing Menveo two-vial presentation will be available in limited amounts, and it will be important to target this product for use in children aged 2 months through 2 years of age at high risk for Meningococcal disease. This product is the only meningococcal conjugate vaccine approved for use in this age group. Requests for the limited Menveo two-vial vaccine will have a minimum order size of 1 dose with a maximum request of 5 doses.
As of June 2, 2022, Menactra has been discontinued and is no longer available. However, Menveo and MenQuadfi are available to order.
Rotavirus Vaccine:
As of March 6, 2023, ROTARIX (NDC 58160-0854-52, a vial and oral dosing applicator) is discontinued and no longer available. However, ROTARIX (NDC 58160-0740-21, an oral dosing applicator only presentation) is available to order.
Influenza Vaccine Supply Information:
The VFC Program has started shipping available flu doses for the 2025-2026 flu season. If you have any doses remaining in your inventory from the previous season, please submit a return form in myCAvax and return them to McKesson with the prepaid shipping label provided. Currently, Fluarix, Flucelvax, and FluLaval are the only products available in supply large enough to ship. All other products will ship once supply is available. Providers that pre-booked can expect shipments the week of August 19. For providers that did not submit a pre-book, allocations have been added to your accounts. Please feel free to submit your order up to the amounts allocated to your location.
| Products |
Dose Volume |
Age Group |
Currently available? |
| Fluarix® pre-filled syringes, GSK |
0.5 mL |
6 months-18 years |
No
|
| Flucelvax® pre-filled syringes, Seqirus |
0.5 mL |
6 months-18 years |
No
|
| FluLaval® pre-filled syringes, GSK |
0.5 mL |
6 months-18 years |
No
|
| Fluzone® pre-filled syringes, Sanofi |
0.5 mL |
6 months-18 years |
No
|
| FluMist® pre-filled syringes, AstraZeneca |
0.2 mL |
2 years-18 years |
No
|
PREVENT DELAYS:
- Login to myCAvax to verify that your clinic’s hours of operation are updated. This ensures a timely delivery of your vaccine shipments and prevents undeliverable shipment attempts which may lead to vaccine being spoiled.
Additional Resources
Ordering & Distribution Calendars